MP Lecart - Concepedia

Author

MP Lecart

University of Liège

Also Known As

M P Lecart, M. P. LECART, M. P. Lecart, M.-P. Lecart, M.P Lecart, M.P. Lecart, MP Lecart

Publications

691

Citations

H-Index

Concepts

All Affiliations

University of Liège Centre Hospitalier Universitaire de Liège

About

MP Lecart is an author at University of Liège specializing in medicine, osteoporosis, and bone health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	441
2	Health Sciences	2	2	125
3	Endocrinology	2	2	125
4	Obstetrics	2	2	125
5	Public Health	1	1	66

MP Lecart

Publications

550

Citations

H-Index

Page 1

	Year	Citations
1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN Jean‐Yves Reginster, Adelin Albert, MP Lecart, The Lancet Bone DiseaseBone HealthBone MetabolismOrthopaedicsBone Density	1987	202
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin J.-Y. Reginster, D. Denis, Rita Deroisy, Journal of Bone and Mineral Research	1994	68
Thromboxane and prostacyclin release in adult respiratory distress syndrome G. Deby‐Dupont, Marc Braun, Maurice Lamy, Intensive Care Medicine Heart FailureRespiratory Distress Syndrome (Pulmonary Critical Care)SepsisRespiratory Distress Syndrome (Neonatal Medicine)Prostacyclin Release	1987	66
Preliminary report of decreased serum magnesium in postmenopausal osteoporosis. Jean‐Yves Reginster, Linda Strause, Rita Deroisy, PubMed GynecologyOsteoporosisOrthopaedic SurgeryBone DiseaseBone Mg Levels	1989	66
Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics. Jean‐Yves Reginster, Rita Deroisy, Adelin Albert, Journal of Clinical Investigation Ct ProductionGynecologyOsteoporosisMetabolic SyndromePlasma Levels	1989	59
Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of bone Jean‐Yves Reginster, A.M. Jeugmans-Huynen, Adelin Albert, Bone Bone DiseaseBone ImagingBone HealthOsteopathyThiomethylene Bisphosphonate	1988	48
Influence of Specific Anti-Salmon Calcitonin Antibodies on Biological Effectiveness of Nasal Salmon Calcitonin in Paget's Disease of Bone Jean‐Yves Reginster, C. Gennari, C. Mautalén, Scandinavian Journal of Rheumatology	1990	26
Paget's disease of bone treated with a five day course of oral tiludronate. J.-Y. Reginster, MP Lecart, Rita Deroisy, Annals of the Rheumatic Diseases	1993	15

Page 1